REGULATORY FOCUS – New reports address generics pricing, innovation in the EU

Supply crunch for essential cancer medicines shows the… 16 February 2022 Reports of supply shortages of breast cancer medicine (Tamoxifen) in…
One- Pager: New pricing models for generic medicines 10 October 2022 How can we ensure a sustainable healthcare system while safeguarding…
Interview: Medicines for Europe Reports on EU Biosimilar… 27 July 2020 The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven,…
EURACTIV - Adjust prices to save drugs, generics industry… 6 February 2023 The generics industry is urging EU and national governments to…